Literature DB >> 26420132

A rare variant association test in family-based designs and non-normal quantitative traits.

Lajmi Lakhal-Chaieb1, Karim Oualkacha2, Brent J Richards3,4,5, Celia M T Greenwood3,4,6.   

Abstract

Rare variant studies are now being used to characterize the genetic diversity between individuals and may help to identify substantial amounts of the genetic variation of complex diseases and quantitative phenotypes. Family data have been shown to be powerful to interrogate rare variants. Consequently, several rare variants association tests have been recently developed for family-based designs, but typically, these assume the normality of the quantitative phenotypes. In this paper, we present a family-based test for rare-variants association in the presence of non-normal quantitative phenotypes. The proposed model relaxes the normality assumption and does not specify any parametric distribution for the marginal distribution of the phenotype. The dependence between relatives is modeled via a Gaussian copula. A score-type test is derived, and several strategies to approximate its distribution under the null hypothesis are derived and investigated. The performance of the proposed test is assessed and compared with existing methods by simulations. The methodology is illustrated with an association study involving the adiponectin trait from the UK10K project.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Gaussian copulas; Kernel machine regression; association tests; rare variants; region-based tests; score test; variance components

Mesh:

Substances:

Year:  2015        PMID: 26420132     DOI: 10.1002/sim.6750

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Software Application Profile: RVPedigree: a suite of family-based rare variant association tests for normally and non-normally distributed quantitative traits.

Authors:  Karim Oualkacha; Lajmi Lakhal-Chaieb; Celia Mt Greenwood
Journal:  Int J Epidemiol       Date:  2016-04-16       Impact factor: 7.196

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.